Skip to main content
. 2014 Feb;58(2):795–800. doi: 10.1128/AAC.01531-13

TABLE 4.

Distribution of tigecycline MICs for 650 Nocardia isolates

Organism (n)a No. of isolates for which the tigecycline MIC (μg/ml) was:
≤0.06 0.12 0.25 0.5 1 2 4 ≥8
N. abscessus complex (39) 10 7 7 10 5 0 0 0
    N. abscessus complex, MDR (0)
N. amamiensis (1) 0 0 1 0 0 0 0 0
N. amikacinitolerans (5) 0 0 0 0 3 1 1 0
    N. amikacinitolerans, MDR (3) 0 0 0 0 1 1 1 0
N. aobensis (2) 0 0 0 0 1 0 1 0
    N. aobensis, MDR (1) 0 0 0 0 0 0 1 0
N. asteroides sensu stricto (2) 0 1 0 0 0 1 0 0
N. beijingensis complex (18) 2 2 1 4 7 1 1 0
N. blacklockiae (1) 0 0 0 0 1 0 0 0
N. brasiliensis (88) 7 36 21 18 5 1 0 0
    N. brasiliensis, MDR (34) 3 9 12 6 3 1 0 0
N. cyriacigeorgica (128) 0 7 9 39 44 24 5 0
    N. cyriacigeorgica, MDR (12) 0 0 2 4 3 2 1 0
N. exalbida complex (1) 0 0 0 0 1 0 0 0
N. farcinica (102) 0 2 0 2 6 18 58 16
    N. farcinica, MDR (65) 0 1 0 1 4 5 40 14
N. flavorosea (1) 0 1 0 0 0 0 0 0
N. ignorata (1) 0 0 1 0 0 0 0 0
N. neocaledoniensis (1) 0 0 0 1 0 0 0 0
N. niigatensis (1) 0 0 0 0 1 0 0 0
N. nova complex (162) 4 1 11 25 41 51 28 1
    N. nova complex, MDR (2) 0 0 0 0 1 1 0 0
        N. nova (132) 4 1 9 22 32 38 25 1
            N. nova, MDR (2) 0 0 0 0 1 1 0 0
N. otitidiscaviarum (17) 2 3 4 3 5 0 0 0
N. paucivorans (5) 0 4 0 0 1 0 0 0
N. pseudobrasiliensis (7) 0 0 0 1 2 1 3 0
    N. pseudobrasiliensis, MDR (7) 0 0 0 1 2 1 3 0
N. puris (1) 0 1 0 0 0 0 0 0
    N. puris, MDR (1) 0 1 0 0 0 0 0 0
N. rhamnosiphila (2) 0 0 1 1 0 0 0 0
N. takedensis (1) 0 0 0 1 0 0 0 0
N. thailandia (1) 0 0 0 1 0 0 0 0
N. transvalensis complex (41) 0 0 4 4 11 12 9 1
    N. transvalensis complex, MDR (20) 0 0 0 1 4 8 6 1
N. vermiculata (1) 0 0 1 0 0 0 0 0
N. yamanashiensis (1) 0 0 0 1 0 0 0 0
Nocardia sp. (16) 2 4 2 4 3 0 0 1
Total (650) 27 69 64 115 139 111 106 19
a

Distribution of tigecycline MICs for the species N. nova is provided independently from that for the larger N. nova complex. Multidrug-resistant (MDR) Nocardia spp. were defined as those with resistance to two or more of the most commonly used drugs (amikacin, ceftriaxone, TMP-SMX, and imipenem).